Posted in Uncategorized on January 31, 2017
Johnson & Johnson has been a leading name in infant and childcare products for more than 130 years. Johnson & Johnson talcum powder, or baby powder, is a staple in thousands of American households – not just for use on babies, but for men and women as well. Adults have used talcum powder for moisture wicking and to prevent chafing almost since its creation. Today, Johnson & Johnson brand faces a major lawsuit for allegedly contributing to ovarian cancer in thousands of women with this very product.
Talcum Powder and Ovarian Cancer
Since the 1970s, researchers have published studies exploring the effects of talc particles around female genitalia, linking the particles to ovarian tumors. Talc is a mineral made of silicon, oxygen, and magnesium. Some talc contains asbestos, a dangerous carcinogen, in its natural form. In the studies, some scientists found talc particles embedded in multiple ovarian tumors they tested. Other studies, however, have not found an increased risk of ovarian cancer in women who use talcum powder. Women who use talcum powder may unknowingly be introducing harmful particles into their reproductive systems.
The Savannah personal injury attorneys at Roden + Love found that plaintiffs have filed more than 2,000 individual and class action lawsuits against Johnson & Johnson, claiming the manufacturer knew of the link between talcum powder and ovarian cancer and did nothing to warn consumers. Consumers have used baby powder for cosmetic and personal hygiene reasons since about the early 1900s, with no warnings of its possible link to cancer in women. In the last few years, Johnson & Johnson has faced controversy for failing to include a warning on its talcum products.
In October 2016, Johnson & Johnson had to pay a $70 million settlement award to a plaintiff whose doctor diagnosed her with ovarian cancer in 2012 after using talc powder for feminine hygiene purposes. This followed a May 2016 settlement of $55 million for an ovarian cancer lawsuit brought by a woman named Gloria Ristsund. Although Johnson & Johnson is pursuing appeals, many similar cases are still going to trial, including cases that are pending in Canada. One such case is a new federal lawsuit set to go to trial February 6, 2017.
Information on the Latest J&J Talcum Powder Lawsuit
The federal court in New Jersey and state courts in California and Missouri currently hold the 2,000-plus cases that are pending. More than 60 women and family members are bringing the latest class action lawsuit against Johnson & Johnson in Missouri, with five additional trials coming afterward. This lawsuit began its litigation in June 2016 in the Missouri Circuit Court for St. Louis City. At this trial, the judge issued a trial starting date of February 6, 2017. This trial involves six plaintiffs who claim that their repeated use of Johnson & Johnson talcum powder products led to or contributed to their development of ovarian cancer.
As of January 6, 2017, the Missouri Court of Appeals has opened its courts to 1,350 plaintiffs who are not residents of Missouri – a major victory for people suffering injuries that may relate to J&J’s products and lack of warning labels. This is a victory since plaintiffs have managed to recover three major verdicts in Missouri courts so far, as opposed to courts in New Jersey (where J&J has its headquarters) dismissing the cases.
Johnson & Johnson continues to adamantly defend the safety of its talc products, stating that its baby powder has a “long history of safe and gentle use.” If you or a loved one suffered an ovarian cancer diagnosis and have a history of regular use of Johnson & Johnson talcum powder in the vaginal region, you may have the right to join a class action lawsuit in Georgia. It’s important to speak with a specialized Savannah talc attorney to discuss your options.